Aligos Therapeutics Inc

Aligos Therapeutics Inc is a biotechnology company that focuses on the discovery and development of innovative therapies for viral and liver diseases. The company was founded in 2018 and is headquartered in South San Francisco, California.

The main goal of Aligos Therapeutics is to tackle significant unmet medical needs in diseases caused by viral infections, particularly those affecting the liver. The company utilizes its expertise in virology and liver biology to develop novel approaches for antiviral drug discovery, viral disruption, and immune modulation.

One of the key areas of focus for Aligos Therapeutics is chronic hepatitis B virus (HBV) infection, a global health problem affecting millions of people and causing significant morbidity and mortality. The company*s lead product candidates target HBV by aiming to inhibit the viral replication and pathogenesis, ultimately achieving sustained virologic suppression and promoting immune-mediated clearance of the virus.

Aligos Therapeutics utilizes a variety of approaches to develop its therapies, including small molecule inhibitors, oligonucleotides, and RNA interference. The company*s drug discovery platform is based on a deep understanding of the viral life cycle, host-virus interactions, and disease pathogenesis.

With a team of experienced scientists and researchers, Aligos Therapeutics conducts rigorous preclinical and clinical studies to evaluate the safety, efficacy, and mechanism of action of its drug candidates. The company collaborates with leading academic institutions, pharmaceutical companies, and research organizations to leverage their expertise and resources in advancing its pipeline of drug candidates.

Apart from the HBV program, Aligos Therapeutics is also actively involved in the development of treatments for other viral and liver diseases, including chronic hepatitis delta virus (HDV) infection, non-alcoholic steatohepatitis (NASH), and liver fibrosis. These diseases represent significant unmet medical needs and global health burdens.

In summary, Aligos Therapeutics Inc is a biotechnology company focused on developing innovative therapies for viral and liver diseases. Through its deep understanding of virology and liver biology, the company aims to make a significant impact in the field of antiviral drug discovery and treatment.